Theranostics World Congress

In 2011, a nuclear medicine physician and a radiochemist, namely Prof. Dr. Richard P. Baum and Prof. Dr. Frank Rösch, founded the very first Theranostics World Congress (TWC) in the field of nuclear medicine covering the topics Gallium-68 and Peptide Receptor Radionuclide Therapy - THERANOSTICS – on the Way to Personalized Medicine. Since then, the TWC has developed as the most important forum for mutual exchange and a true bench to bedside view on scientific and clinical developments. With this 360° perspective on Theranostics and Radiomolecular Precision Oncology, the TWC is truly a platform for all players in this exciting field. And this worldwide! From Europe to India over America to Australia and Asia, the TWC was held in several venues around the world. Over the years, the field of Theranostics has been growing outstandingly with an exponential increase in publications, new clinical indications, promising novel radioisotopes, and new treatment concepts. Even 10 years after the first TWC took place, the exciting fields of Theranostics and Radiomolecular Precision Oncology are still at its beginnings. We want to take a 360° view on the wide field of Theranostics in Radiomolecular Precision Oncology.